From Teriparatide to Pembrolizumab: CDSCO Clears Import of r-DNA Drugs via CT-18 Route Susmita Roy26 Jan 2026 1:58 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and December 2025 for...
CDSCO Panel Grants Go Ahead for Levim Lifetech's Phase I/III Teriparatide Trial Susmita Roy26 Jan 2026 1:46 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of permission to Levim...
Macleods Gets CDSCO Panel Nod to Conduct BE Studies for Semaglutide Prefilled Pens Susmita Roy25 Jan 2026 11:36 PM ISTNew Delhi: Accepting the toxicity data submitted by Macleods Pharmaceuticals, the Subject Expert Committee (SEC) functioning under the Central Drugs...
CDSCO Finds 93 Medicines Samples Substandard, Key Antibiotics, Chronic Drugs Affected Susmita Roy25 Jan 2026 3:00 PM ISTNew Delhi: Highlighting continuing concerns over drug quality in India's pharmaceutical supply chain, the Central Drugs Standard Control Organisation...
CDSCO Clears Over 100 rDNA Drugs and Biologics Between 2020-25, Boosting Access to Advanced Therapies Susmita Roy23 Jan 2026 5:09 PM ISTNew Delhi: India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA...
CDSCO Flags 7 Batches of Popular Medicines as Purportedly Spurious in December Susmita Roy23 Jan 2026 3:51 PM ISTNew Delhi: In a disclosure that raises serious concerns over drug authenticity and patient safety, the Central Drugs Standard Control Organisation...
CDSCO Flags 74 Drugs, Devices Samples as NSQ in December: Zerodol-SP, Defcort, Telmisartan, Amikacin Among Failed Products Susmita Roy22 Jan 2026 7:18 PM ISTNew Delhi: As part of a nationwide quality surveillance drive, the Central Drugs Standard Control Organisation (CDSCO) has flagged 74 drugs,...
CDSCO to Reject Long-Pending SUGAM Applications After 30 Days for Non-Response to Queries Susmita Roy18 Jan 2026 5:58 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has announced that it will dispose of and reject long-pending applications...
Johnson and Johnson Gets CDSCO Panel Nod for Talqetamab in Relapsed Multiple Myeloma, Phase IV Trial Mandated Parthika Patel15 Jan 2026 10:56 PM ISTNew Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of permission to...
Health Ministry Appoints Two New Drug Inspectors Under Drugs and Cosmetics Act Susmita Roy14 Jan 2026 10:30 AM ISTNew Delhi: The Union Ministry of Health and Family Welfare has appointed two new inspectors under the Drugs and Cosmetics Act, 1940, authorizing them...
Madras HC Upholds Centre's One-Year Contract Extension of DCGI Susmita Roy13 Jan 2026 9:03 PM ISTNew Delhi: One of the most closely watched controversies in India's pharmaceutical sector last year, surrounding the continuation of the Drugs...
CDSCO Panel Backs Label Change Allowing Endocrinologists, Rheumatologists to Prescribe Amgen's Romosozumab Parthika Patel12 Jan 2026 9:12 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO), has recommended approval for amending the...
